GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read More

GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read More
Czechia has launched a major cancer prevention centre in Brno at the Masaryk Memorial Cancer Institute, funded through a €46.1…
Read More
Merck's cancer drug KEYTRUDA (pembrolizumab), combined with Padcev (enfortumab vedotin-ejfv), has received a positive recommendation from the European Medicines Agency's…
Read More
CONGERS, NY – May 05, 2026 – A shock-absorbing pad designed to safely handle a gamer’s moment of frustration has…
Read MoreOpen this photo in gallery: The Terry Fox Foundation launched the Cancer Breakthrough Fund in partnership with Lumira Ventures in…
Read More
A current review has discussed how to build lung cancer screening programmes sustainable – not only in terms of costs…
Read More
Few fires burn as fiercely as the one driving Dr. Efraín Torres, a 2019 Marquette biomedical engineering alumnus and CEO…
Read More
When Surbhi Sarna was a teenager dealing with painful ovarian cysts, she came face-to-face with a troubling gap in modern…
Read More
I want to receive customized email newsletters from Watch Medier A/S , including information about our brands and group companies…
Read More
Hello, After sparking concerns in the US and Europe over its potential apply to destabilise banking systems, Anthropic’s frontier AI…
Read More